1.
Mehić B, Stanetić M, Tinjić L, Smoljanović V. Our Experiences with Erlotinib in Second and Third Line Treatment Patients with Advanced Stage Iiib/ Iv Non-Small Cell Lung Cancer. Bosn J of Basic Med Sci [Internet]. 2008Nov.20 [cited 2021Mar.7];8(4):386-90. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/2905